Sorrento Therapeutics Inc (NASDAQ:SRNE)

11.31
Delayed Data
As of Apr 17
 +0.16 / +1.43%
Today’s Change
3.10
Today|||52-Week Range
14.30
+12.31%
Year-to-Date
No recent news for Sorrento Therapeutics Inc.

Today’s Trading

Previous close11.15
Today’s open11.20
Day’s range11.06 - 11.43
Volume223,784
Average volume (3 months)292,047
Market cap$403.7M
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-192.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-21.18%
P/E ratioNM
Price/Sales264.85
Price/Book3.84

Competitors

 Today’s
change
Today’s
% change
SPPISpectrum Pharmaceuti...-0.12-1.97%
SNTASynta Pharmaceutical...-0.10-3.30%
AMPEAmpio Pharmaceutical...-0.10-1.25%
VNDAVanda Pharmaceutical...-0.19-1.88%
Data as of 4:03pm ET, 04/17/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$460.1K
Annual profit (last year)-$21.9M
Net profit margin-4,761.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Henry H. Ji
Chief Financial &
Accounting Officer
Douglas J. Langston
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers